NCT03457831 Status Epilepticus in the Critically Ill Patients
| NCT ID | NCT03457831 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ictal Group |
| Condition | Status Epilepticus |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2018-02-28 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2018-02-28 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Convulsive and Non Convulsive Status Epilepticus (SE) and Pseudo Status Epilepticus prospective registry. Data collection using a standardized form : demographic data and data related to the SE, including circumstances of onset, dates and times of onset and of seizure control, on-scene clinical findings, clinical features of the seizures, pre-hospital and hospital care providers, timing of antiepileptic and supportive treatments, results of etiological investigations, cause of SE, type and dosage of antiepileptic drugs. Dates and times of EEG monitoring, EEG results. Outcomes including vital status and Glasgow Outcome Scale score at ICU and hospital discharge, day-90 and 1-year after SE and determined based on data in the ICU and/or neurologist charts and/or patients phone interview.
Eligibility Criteria
Inclusion Criteria: * SE defined as 5 min or more of (i) continuous clinical and/or electrographic seizure activity or (ii) recurrent seizure activity without recovery (returning to baseline) between seizures. * age \>= 18 years Exclusion Criteria: * age \< 18 years * postanoxic status epilepticus
Contact & Investigator
stephane LEGRIEL, MD
PRINCIPAL INVESTIGATOR
Ictal Group
Frequently Asked Questions
Who can join the NCT03457831 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Status Epilepticus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03457831 currently recruiting?
Yes, NCT03457831 is actively recruiting participants. Contact the research team at slegriel@ch-versailles.fr for enrollment information.
Where is the NCT03457831 trial being conducted?
This trial is being conducted at Angoulême, France, Beauvais, France, Beuvry, France, Brest, France and 11 additional locations.
Who is sponsoring the NCT03457831 clinical trial?
NCT03457831 is sponsored by Ictal Group. The principal investigator is stephane LEGRIEL, MD at Ictal Group. The trial plans to enroll 1,000 participants.